Venture Capital
-
Fitz Gate closes Fund III anchored by Rice’s Office of Innovation
Rice University’s Office of Innovation is one of the anchor investors in Fitz Gate’s Fund III, which has brought the firm’s AuM to around $70 million.
-
UNSW Canberra backs the ACTivate Capital Fund
The ACTivate Capital Fund was set up by the government of the Australian Capital Territory to invest in startups and spinouts in Canberra.
-
Breakthrough Victoria backs the SYNthesis BioVentures Fund I
Created by Monash University’s Prof Andrew Wilks, the SYNthesis BioVentures Fund I works with Australian research institutes to scale their spinouts.
-
Creator Fund raises $41 million for pan-European fund
The venture fund targets startups built by PhD students, and Creator Fund is targeting a $55 million final close by early 2026.
-
Robert Langer, prolific MIT spinout founder, launches $77.5 million fund
T.Rx Capital has closed its inaugural fund at $77.5 million to build and invest in healthcare startups, with Langer’s son also among the firm’s co-founders.
-
Venture Investors Health Fund raises $80 million to back spinouts
Venture Investors Health Fund has secured $80 million to invest in spinouts from institutions such as the University of Michigan.
-
Brandon Capital collects A$439 million for sixth fund
Australasian life sciences VC Brandon Capital has a partnership with more than 50 research institutions that provide access to deals.
-
Catalio closes Nexus Fund IV with $400 million
Catalio Capital Management specialises in launching and investing in life sciences spinouts through a network of researchers that act as venture partners.
